Tudor Financial Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.8% in the 1st quarter, HoldingsChannel.com reports. The firm owned 1,728 shares of the healthcare conglomerate’s stock after selling 49 shares during the period. Tudor Financial Inc.’s holdings in UnitedHealth Group were worth $905,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of recent analyst reports. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. Deutsche Bank Aktiengesellschaft lowered their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a report on Monday, May 19th. Raymond James cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Finally, Royal Bank of Canada lowered their price target on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $426.52.
UnitedHealth Group Trading Down 1.6%
NYSE UNH opened at $313.39 on Friday. The business’s 50-day moving average price is $386.66 and its two-hundred day moving average price is $474.19. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $284.28 billion, a PE ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. UnitedHealth Group’s dividend payout ratio is presently 37.02%.
Insider Activity at UnitedHealth Group
In other news, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last 90 days. Corporate insiders own 0.28% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- How to Use the MarketBeat Stock Screener
- Higher Gulf Oil Output Puts These Energy Names in Play
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.